Semaglutide is a drug belonging to the GLP-1 (glycosaminopeptide-1) receptor agonist category used to treat obesity. Its weight loss principle involves various physiological effects, including:

    Insulin release: Semaglutide simulates the effect of GLP-1, prompting the pancreas to release more insulin. This helps to lower blood sugar levels, enabling the body to better utilize glucose and reduce fat storage.

    Inhibition of glucose production: Semaglutide also inhibits the secretion of glucagon in the pancreas, a hormone that increases blood sugar. By reducing the secretion of glucagon, it helps to lower blood sugar levels.

    Delaying gastric emptying: Semaglutide slows down the rate of food emptying in the stomach, making it easier for people to feel full. This helps to reduce food intake and appetite.

    Central nervous system function: Semaglutide regulates appetite and hunger by acting on specific regions of the brain, thereby helping to reduce eating and control weight.

    Clinical studies have shown that Semaglutide is very effective in treating obesity. Patients typically achieve significant weight loss when using Semaglutide.